In patients with NASH, the increased number CD8 T cells in the liver correlates with elevated frequency of blood CD8 T cells expressing perforin, IFNγ, and TNFα, raising the possibility of systemic activation or crosstalk with other tissues (50). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.